Europe against cancer programme: Report on the implementation of the first plan of action, 1987-1989. Communication from the European Commission to the Council, the European Parliament and the Economic and Social Committee. COM (90) 185 final, 8 May 1990 by unknown
COMMISSION  OF  THE  EUROPEAN  COMMUNITIES 
COK(90)  185  final 
Brussels.  8  Kay  1990 
.  •EUROPE  AGAINST  CANCER•  PROGIWI&E: 
REPORT  ON  THE  IMPLEMENTATION  OF  THE  FIRST  PLANT  OF  ACTION,1187-1889 
CC.unlcat lon  fr~ the Euroc)ean  ec:-laalon to the Council, 
the European  Parll ...  nt and  the Econoalc  and  SOcial  CO..Ittee T A B L E  0  F  C  0  N  T  E  N  T  S 
INTRODUCTION 
CHAPTER  1  :  CANCER  PREVENTION 
I.  Campaign  against  tobacco  2 
I I.  Improvement  In  nutrition  7 
I I I.  Protection against  carcinogenic  agents  11 
IV.  Systematic  screening  and  early diagnosis  13 
V.  "European  Code  agaInst  cancer"  14 
CHAPTER  2  :  INFORMATION  AND  HEALTH  EDUCATION 
I.  Informing  the  general  public  15 
II.  Health  education  17 
CHAPTER  3  TRAINING  OF  THE  HEALTH  PROFESSIONS  19 
CHAPTER  4  CANCER  RESEARCH  21 
CONCLUSION  31 
*  *  * 
TABLES 
Changes  In  the  percentage of  non-smokers  during  6b 
the  first  action  plan  1987-1989 
Evolution of  the  notoriety of  the  European  Code  17b 
during  the  European  Year  of  lnforma~lon on  Cancer - 1  -
•EUROPE  AGAINST  CANCER•  PROGRAWNE: 
REPORT  ON  THE  IMPLEMENTATION  OF  THE  FIRST  PLAN  OF  ACTION,  1987-1989 
The  "Europe  against  cancer"  programme  was  launched  on  the  Initiative of 
the  Heads  of  State  and  ·Government  of  the  European  CommunIty  meetIng  In 
Milan  In  June  1985.  Acting  on  proposals  from  the  European  Commission, 
and  following  favourable  opinions  from  the  European  Parliament,  the 
Council  adopted  three  basic  texts  defining  the  overall  framework  and 
financial  provisions  for  the  programme: 
a)  Resolution  of  7  July  1986  (OJ  No  c  184,  23.7.1986),  which 
concentrated on  prevention and  health education; 
b)  DecIsIon  of  7  November  1986  (OJ  No  L  334,  24.11 .1987)  on  medIca I 
research; 
c)  Decision  of  17  May  1988  (OJ  No  L  160,  28.6.88)  on  Informing  the 
publ lc  and  training medical  personnel. 
Also  In  1986,  the  Commission  prepared·a  detailed  plan  of  action  for  the 
period  1987-1989.  This  75-polnt  plan  was  published  In  the  Official 
Journal  (C  50,  26.2.1987,  pp.  1-55).  It  constitutes  the  first  stage  of 
the  programme,  the  oblectlye  of  which  Is  to  reduce  the  expected  number 
of  deaths  due  to  cancer  by  15%  (from  1  000  000  to  850  000)  by  the  year 
2000.  To  achieve  this ambitious goal,  the  European  Commission  adopted  a 
"partnershiP  approach"  aimed  at  Involving  everyone  concerned  with  the 
fight  against  cancer  at  national  level: 
the  Committee  of  Cancer  Experts,  the  scientific  soul  of  the 
programme; 
the  cancer  associations and  leagues  and  anti-smoking organizations  In 
the  European  Community,  the  spearheads of  the  programme; 
the  producers  of  television  medical  programmes,  who  have  helped  to 
spread  the message  of  cancer  prevention; 
the  representatives of  general  practitioners,  who  play  a  central  role 
In  early detection and  systematl~ screening  for  cancer; 
senior officials  In  the  health,  education and  research ministries. 
Of  course,  It  Is much  too  early  to  Identify  any  possible  fa! l-oft  In  the 
growing  number  of  cancer  deaths  In  the  European  Community.  It  Is, 
however,  no  problem  at  all  to  take  stock  of  achievements  under  each  of 
the  75  Actions  announced  at  the  beginning  of  1987.  An  overall 
assessment  Is  contained  In  the  conclusion on  page  31. 
*  * 
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CHAPTER  1;  CANCER  PREVENTION 
!.  CAMPAIGN  AGAINST  TABACCQ 
Action  1;  Upward  alignment  of  taxation  on  tobacco  manyfactyred  In  the 
European  Commyn!ty 
a)  On  7  August  1987,  as  part  of  the  process  towards  completing  the 
internal  market,  the  Commission  presented  two  proposals  for  Directives 
(COM(87)325  and  COM(87)326)  on  the  approximation  of  taxes  on  cigarettes 
and  on  manufactured  tobacco other  than cigarettes. 
The  proposal  on  cigarettes  required  the  tax  burden  In  the  European 
Community  to  be  Increased  by  more  than  30  % before  1  January  1993.  In 
at  least  nine  of  the  twelve  Member  States  this  meant  very  sharp 
Increases  In  taxes  and  prices  (more  than  150%  In  some  cases).  but  In 
three  countries prices would  have  fallen. 
The  price  and  tax  Increases  for  manufactured  tobacco  other  than 
cigarettes  (cigars,  cigar I !los,  type  tobacco,  snuff  and  chewing  tobacco) 
would,  generally  speaking,  have  affected  the  countries  whtl  the  highest 
consumption 
The  1987  proposals,  which  required  the  unanimous  approval  of  the  Member 
States  If  they  were  to  become  I  aw,  gave  rIse  to  fervent  dIscuss Ions 
within  the  Council  and  European  Pari lament,  but  were  not  adopted.  The 
Member  States  and  the  European  Parr lament  took  the  view  that  the 
Introduction  of  an  element  of  flexlbll lty  In  the  rates  proposed  was  the 
only  way  of  progressing  towards  harmonization. 
b)  Consequently,  on  19  December  1989,  the  Commission  officially 
presented  Its  amended  proposa I  for  a  Counc I I  DIrectIve  on  the 
approximation  of  taxes  on  cigarettes and  manufactured  tobacco other  than 
cigarettes  (COM  (89)525  final).  According  to  the  amended  proposal: 
on  1  January  1993  each  Member  State  will  be  required  to  apply  rates 
higher  than,  or  equal  to,  minimum  rates set  for  each  product  category 
(In  the  Member  States  as  a  whole,  this  approach  will  allow  the 
maintenance  or  the  Increase  of  the  fiscal  burden  to  a  level  more 
compatible  with  the  requirements  of  pub! lc  health).  This  flexibility 
must  under  no  91rcumstances  jeopardize  the  fundamental  principle  of 
abo! ltlon of  customs  and  tax  frontiers  by  1  January  1993; 
after  1  January  1993,  this  Initial  flexibility  must  gradually  give 
way  to  a  mouvement  towards  target  rates  compatible  with  essential 
pub! lc  health  requirements.  To  this  end,  the  target  rates  have  been 
significantly  Increased  compared  to  those  proposed ·In  1987. - 3  -
Action  2:  Financing  of  nreyent!ye  actions  at  national  !eye!  by  the  use 
of  Increased fiscal  measures on  tobacco 
No  action  of  this  type  was  taken  by  the  Member  States  under  the  first 
plan  of  action  1987-89.  However,  discussions  have  started  In  some 
countries,  e.g.  France,  between  the  authorities  and  both  sides  of 
Industry,  with  a  view  to  removing  tobacco  from  the  price  Index  (cf. 
action  3)  In  return  for  an  Increased  effort  by  the  authorities  In  the 
field  of  cancer  screening.  Exemplary  measures  have  been  taken  In 
certain  non-Community  countries  such  as  Australia,  where  the  State  of 
South  Australia  Increased  tax  on  tobacco  products  to  finance  health 
promotion  pub! Ietty  - thus  helping  to  compensate  for.  the  loss  to 
advertising agencies  caused  by  the  total  ban  on  tobacco  advertising. 
Action  3:  Publication  of  Indices  excluding  tobacco  by  tho  Statistical 
Office of  tho  European  Communities 
Since  July  1989  a  price  Index  excluding  tobacco  has  been  published 
monthly  by  the  Statistical  Office  of  the  European  Communities. 
Comparing  price  Index  trends  with  and  without  tobacco  reveals  that  the 
price  of  tobacco  In  real  terms- calculated  on  the  general  consumption 
price  Index  - fel I  during  the  period  covered  by  the  first  plan of  action 
(December  1989  compared  with  December  1986)  In  four  countries,  namely 
the  United  Kingdom  (- 9.4%),  Denmark  (- 8.9%),  Spa'tl)/ (- 5.2%)  and 
Netherlands  <- 0.2%).  This  contrasts  with  an  lncrea~e-in real  terms  in 
the  other  eight  countries  Federal  Republ lc  of  Germany  (+  0.6%), 
Ireland(+ 1.3%),  Luxembourg(+  2.6%),  Portugal  (+  4%),  France(+ 6.9%), 
Italy(+ 7.5%),  Belgium(+  10.3%)  and  Greece(+  27.1%). 
Action  4;  Harmonization  of  cigarette  labelling  In  tho  European 
communities 
On  4  February  1988  the  Commission  submitted  a  proposal  for  a  Council 
Directive,  on  the  basis  of  Article  100A  of  the  EEC  Treaty  (qualified 
majority),  concerning  harmonization of  the  label I log  of  tobacco· products 
(O.J.  C48,  20.2.1988).  The  opinion of  the  Economic  and  Social  Committee 
was  delivered  on  7  July  1988  (O.L.  C237,  12.9.1988),  followed  by  the 
first  reading  of  the  European  Pari lament  on  14  December  1988  (O.J.  C12, 
16.1.1~89).  The  Commission  generally  took  account  of  both  Institutions' 
opinions  In  Its  amended  proposal  (O.J.  C62,  11.3.1989),  which  served  as 
a  basis  for  the  Council's  common  position  of  16  May  1989.  Following  a 
favourable  vote  at  the  second  reading  by  the  European  Parliament,  the 
Council  adopted  this  Directive  on  13  November  1989  (O.J.  L359, 
8.12.1989).  Article 4  states that: 
AI  I  unit  packets of  tabacco  products  shal I  carry,  on  the  most  visible 
surface,  the  following  general  warning  In  the  official  language  or 
languages  of  the  country  of  final  marketing:  "Tobacco  seriously 
damages  health"  (Article  4  (1)); - 4  -
With  regard  to  cigarette  packets  (Article  4  (2),  (3)  and  (4)  and 
Annex>.  the  other  large  surface. shall  carry  alternating  specific 
warnings.  For  this  purpose each  Member  State shall  draw  up  a  list of 
warnings  taken  exclusively  from  those  listed  In  the  Annex  to  the 
Directive. 
The  following  warnlngs_must  be  Included  In  each  Member  State's  list: 
"Smoking  causes  cancer": 
.  "Smoking  causes  heart  disease". 
The  tar  and  nicotine  contents  of  cigarettes  must  also  be  printed  on 
the side of  packets  (Article 2). 
The  Member  States  must  bring  Into  force· the  laws,  regulations  and 
administrative  provisions  needed  to  comply  with  this Directive before  31 
December  1.991 . 
Action  5;  prohibition of cigarettes with a  high  tar content 
On  1  February  1988  the  Commission  presented  a  proposal  for  a  Council 
Directive  (O.J.  C48,  20.2.1988),  on  the  basis of Article  100A  of  the  EEC 
· Treaty.  to  lim! t  the .max !mum  tar  content  of  cigarettes  to  15  mg  by  31 
December  1992  and  12  mg  by  31  December  1995.  On  7  July  1988  the 
Economic  and  Social  Committee  adopted  a  favourable  opinion  (O.J.  C237, 
12.9.1988).  The  European  Parliament  expressed  Its  opinion  on  25  May 
1989  (O.J.  C158,  26.6.1989),  diverging  considerably  from  the 
Commission's  proposal  by  recommending  an  IQitlal  limit  of  20  mg  tar  by 
31  December  1989,  with  the  posslbi 1 lty  of  a  further  reduction  to  15  mg 
by  a  second,  unspecified  date,  after  approval  of  a  report  on  the  socio-
economic  repercussions  of  these  limits.  The  Commission  did  not  see  fit 
to  amend  Its  initial  timetable  In  Its  amended  proposal  (O.J.  C228, 
5.9.1989,  and  O.J.  237,  15.9.1989- corrigendum). 
On  13  November  1989  the  Council  of  Health  Ministers  adopted  a  common 
.position maintaining  the  date  of  31  December  1992  for  the  15  mg  limit 
and  differing  the  date  of  application  for  the  12  mg  limit  until  31 
December1997.  A special  temporary  exemption  was  granted  to Greece  (20  mg 
by  31  December  1992,  18  mg  by  31  December  1998,  15  mg  by  31.12.2000  and 
12  mg  by  31  December  2006). 
On  14  March  1990  the  European  Pari lament  adopted  the  common  position of 
the  Council  at  Its  second  reading,  which  meant  that  the  -Directive 
should  be  adopted  finally  by  the  Council  of  Health  Ministers  on  17  May 
1990. 
Action  6;  Harmonization  of  the  standards  for  measuring  tho  cgmponents 
of  tobacco smoke 
The  council  Directives .on  the  labelling  of  tobacco  products  and  the 
maximum  tar  content  of  cigarettes  reQuire  the  nlcotln  and  tar  contents 
of  cigarettes  to  be  measured  on  the  basis of  standards  ISO  4387  and  ISO 
3400  and  verified  In  accordance  with  ISO  8243. 
The  national  and  European  standardization  Institutes  are  currently 
working  on  ISO  standards  for  measuring  the  tar  and  nlcotln  yields  of 
tobacco  products other  than cigarettes  (rolllng;tobacco,  cigars, etc). 121 
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Action  7;  Prohibition  of  tax-free  sales  of  tobacco  In  the  Eurooean 
eonmun I ty 
Proposals  wl  I 1 be  drawn  up  under  the  second  plan of  action,  1990-94. 
Action 8;  Protection of  children from  tobacco sales 
After  consulting experts,  the  European  Commission  decided  not  to draw  up 
a  proposal  for  a  Directive  prohibiting  the  set ling  of  tobacco  products 
to  minors.  In  several  countries,  particularly  In  southern  Europe,  such 
a  ban  could  encourage  young  people  to  smoke  for  the  sh,eer  thrill  of 
breaking  the  law. 
The  European  Commission  felt  that  Is  was  better  to  Increase  protection 
of  young  peop I  e  through  a  campaIgn  agaInst  tobacco.  Its  propos  a I  on 
I lmltlng  advertising  for  tobacco  products  In  youth  magazines  therefore 
provides  for  a  total  ban  on  tobacco  advertising  (cf.  action  12). 
Action  9;  Reorientation  of  tobacco  Production  towards  less  toxic 
yarletles and  study of  the possibilities of  reconversion 
The  Common  Agricultural  Pol Icy  has  taken  account  of  concern  about  publ lc 
health  by  encouraging  the  reorientation  of  tobacco  production  towards 
less  toxic  varieties  (which  are  also  the  most  popular)  and  promoting 
conversion  to  other  products.  The  following  measures  have  been 
Implemented: 
a)  The  prices  and  premiums  paid  In  1987-1989  for  the  most  toxic 
varieties  were  reduced  by  8-18%.  The  maximum  quantities  for  which  the 
guaranteed  prices  and  premiums  were  payable,  Introduced  In  1988,  has 
been  reduced  by  25%  for  the period  1988-1990. 
b)  The  structural  funds  set  up  In  connection  with  the  CAP  have  been 
used  to  finance  Investments,  e.g.  Irrigation,  necessary  for  conversion 
to  less  toxic  varieties or  other  crops.  The  technological  research  and 
deve I  opment  programme  for  agr I  cuI ture  has  a I  so  fInanced  research  Into 
the  creation of  tobacco  varieties which  are  less  toxic  as  a  result  of  a 
lower  tar  conten,t  or,  by  way  of  diversification,  tobacco  plants 
containing  proteins  which  can  be  used  for  pharmaceutical  purposes.  The 
Integrated  Mediterranean  Programmes  budget  has  also  been  used,  to  the 
amount  of  2.33 ml  I I ion  ECU  over  the  period  1986-1992,  to  finance  changes 
to  less  toxic  varieties  and  for  conversion  of  4030  ha  of  land  used  for 
tobacco,growlng  In  Greece. 
Action  10;  Information  and  oubl rc  awareness  camoalgn  In  the  stryqgle 
against  tabacco 
The  Commission  has  subsidized  a  large  number  of  activities  In  the 
campaign  against  tobacco,  most  of  them  carried  out  by  anti-cancer 
associations  and  leagues  and  anti-smoking  organizations  In  the  twelve 
Member  States.  A  special  effort  was  made.  during  the  European  Cancer 
Information  Year  to  promote  the  first  commandment  of  the  European  Code 
against  Cancer:  "Do  not  smoke.  Smokers,  stop  as  quickly  as  possible and 
do  not  smoke  In  the  presence  of  others."  (cf.  report,  publ lshed 
separately,  on  the  European  Cancer  Information Year). - 6  -
The  table,  next  page,  shows  that  encouraging  results  have  been  achieved 
during  the  first action plan  In  seven  of  the  twelve Member  States. 
The  "Europe  against  Cancer"  programme  also  financed  an  assessment  of  the 
effectiveness  of  legislation  and  the  anti-smoking  campaigns  In  the 
European  Community  over  the  past  40  years.  The  results  of  this  study 
were  pub! !shed  In  1990  In  the  journal  "Scandinavian Oncology". 
Action  11;  Study  of  national  oroyls!ons.  and  deyeloDJDent  of  orooosed 
CommUnity  regulations on  tobacco smoking  In public olaces 
On  16  May  1989  the  Council  and  the  Health  Ministers of  the  Member  States 
adopted  a  Resolution  based  on  a  proposal  from  the  Commission  (OJ  C32, 
8.2.1989),  to  ban  smoking  In  places  open  to  the  public  (OJ  C189, 
26.7.1989).  The  Member  States  have  to  Inform  the  European  Commission 
every  two  years  of  action  taken  In  response  to  this Resolution. 
Action  12;  Study  of  national  proylslons.  and  deyelonment  of  proposed 
Community  regulations  on  the  limitation of  tobacco publicity 
In  September  1989  the  Council  (Internal  Market  Ministers)  adopted  the 
proposal  for  a  Directive  on  the  pursuit  of  television  broadcasting 
activities  (OJ  No  L  298,  17.10.1989).  Article  13  of  this  Directive 
states  that  "All  forms  of  television  advertising  for  cigarettes  and 
other  tobacco  products  shal I  be  prohibited".  This  ban  must  be  effective 
by  3.10.1991  at  the  latest  and  covers  both  direct  and  Indirect 
advertising,  the  latter  being  defined  In  the  29th  recital  as  "forms  of 
advertising  which,  whilst  not  directly  mentioning  the' tobacco  product, 
seek  to  circumvent  the  ban  on  advertising  by  using  brand  names,  symbols 
or  other  distinctive  features  of  tobacco  products  or  of  undertakings 
whose  known  or  main  activities  Include  the  production  or  sale  of  such 
products". 
On  30  March  1989  the  European  Commission  presented  a  proposal  for  a 
Council  Directive  on  the  advertising  of  tobacco  products  In  the  press 
and  by  means  of  bills  and  posters  (OJ  No  c  124,  18.5.1989).  This 
proposal  places  str-ict  controls  on  direct  advertising,  for  example  by 
Imposing  compulsory  health  warnings  identical  to  those  annexed  to  the 
Directive  on  labelling.  Indirect  advertising  Is  totally  banned,  and 
both  direct  and  Indirect  advertising  are  prohibited  fn  publications 
mainly  Intended  for  young  people.  Final Jy,  the  proposal  does  not 
prevent  the  Member  States  from  placing  a  total  ban  on  the  advertising of 
tobacco  products  should  they  so  wish. 
Action  13;  Qomparatlye  analysis of aOtl-smoklng campaigns 
In  cooperation  with  the  World  Health  Organization  and  the  British 
MedIca I  As soc I at I on,  the  European  Comm Iss 1  on  has  he I ped  to  f I nance  a 
report  on  helping  smokers  to  give  up  smoking  (available  In  French, 
English  and  Spanish). CHANGES  IN  THE  PERCENTAGE  OF  NON-SMOKERS  DURING  THE  ACTION  PLAN  1987-1989 
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Action  14:  Information exchange  In  the struggle against  smoking 
In  the  course  of  the  first  plan  of  action  1987-1989,  the  European 
Commission  set  up  the  following  three  Information exchange  structures: 
a  European  group  of  non-governmental  organizations  against  tobacco, 
which  met  four  times  between  1987  and  1989; 
a  group  of  senior  officials  responsible  for  the  campaign  against 
tobacco,  which  also met  four  times; 
the  European  Bureau  for  Action  on  Smoking  Prevention  (BASP),  which 
was  established  In  1988  and  published  six  tnformat Jon  brochures  In 
1988  and  1989. 
Finally,  the  European  Commission  joined  forces  with  the  World  Health 
Organization  and  the  Spanish  Health  Ministry  to  organize  the  first 
European  conference  on  anti-tobacco  policy,  held  In  Madrid  on  7-11 
November  1988  and  marked  by  the  publication  In  French,  English  and 
Spanish  of  a  set  of  ten  brochures·whlch  were  then  widely  distributed  In 
1989,  In  part lcular  to  the  300  part lclpants  In  the  "Europe  against 
cancer"  programme  In  the  twelve  Member  States. 
*  * 
* 
II.  IMPROvEMENT  IN  NUTRITION 
Action  15:  Analysis of exlstlna  Information on  •Hutrltlon and  cancer• 
Several  studies  aimed  at  Improving  knowledge  on  the  possible  ! Inks 
between  nutrition  and  cancer  were  subsidized  under  the  first  plan  of 
action  1987-1989: 
a)  Feasibility  phase  of  prospective  studies  of  the  links  between 
nutrition,  health  and  cancer.  Seven  studies  were  launched  In  the 
Federal  Republic  of  Germany,  United  Kingdom,  Netherlands,  France, 
Italy,  Spain  a.nd  Greece  In  order  to  explore  the  possibility  of 
undertaking  a  very  wide  study  of  these  I Inks  In  the  seven  countries 
mentioned  as  from  1990.  This  would  Involve  monitoring  a  group  of 
around  350.000  persons  over  a  ·period  of  several  years,  through 
nutrition surveys  carried out  every  two  or  three  years  and  correlated 
with  the  subjects'  state of  health.  The  European  Commission  and  the 
WHO's  International  Agency  for  Research  on  Cancer·  are  jointly 
responsible  for  overall  coordination. 
b)  Prospective  study  of  the  anti-promoting  role of  selenium.  Conducted 
by  the  University  of  Limburg  between  1986  and  1989,  this  study 
monitored  120  000  subjects  aged  between  55  and  69  to  assess  the 
possible  protect lve  role  of  selenium,  a  mineral  salt  present  In 
foodstuffs.  The  results will  be  published  In  October  1990. - 8  -
c)  Feasibility  phase  of  a  case  control  study  relat lng  to  the  links 
between  nutrition,  lifestyle  and  the  Incidence  of  breast  and  colon 
cancer  In  the  European  COmmunity.  The  separate  studies  carried  out 
In  nine  Member  States,  namely  the  United  Kingdom,  Netherlands, 
Federal  Republic  of  Germany,  Ireland,  Belgium,  Luxembourg,  Greece, 
Italy  and  Spain,  were  coordinated  by  the  IARC,  and  the  results 
should  be  aval lable  In  mld-1990. 
d)  Case  control  study  of  patients  with  adenomatous  polyps  or  cancer  of 
the  colon.  450  persons  from  Belgium,  France,  the  United  Kingdom, 
Federal  Republic  of  Germany,  Italy  and  Portugal  were  monitored  for 
three  years  to evaluate  the  possible  role  of  diet  on  the  development 
of  the  polyps  and  their  degeneration  Into  cancer  of  the  colon.  The 
study  was  coordinated  by  the  European  Organization  for  Cooperation  In 
Cancer  Prevention  Studies  (ECP),  and  the  results  will  be  published 
towards  the  end  of  1990. 
e)  Case  control  study  of  the  link  between  lifestyle,  especially  diet, 
and  cancers  of  the  pancreas  and  bile  ducts.  This  study  was 
undertaken  In  the  Netherlands,  between  1984  and  1989,  by  the 
Institute  for  Health,  and  Involved  a  group  comprising  189  persons 
with  cancer  of  the  pancreas,  127  persons  with  cancer  of  the  bile 
ducts  and  487  persons  not  suffering  from  either.  AI  I  subjects  were 
Interviewed  twice  to  establish  their  lifestyles  and  dietary  habits. 
The  results wl  I I  be  publIshed  In  1990. 
f)  Case  control  study  of  nutrition,  alcohol  consumption  and  breast 
cancer.  Carried  out  under  the  auspices  of  the  Nutrition  Department 
at  the  Athens  School  of  Public  Health,  this  study,  which  began  In 
1988,  Is  monitoring  600  women  with  breast  cancer  and  a  1200-strong 
control  group.  It  wl  I I  be  completed  by  the  end  of  1990. 
g)  Case  control  study  of  nutrition  and  precancerous  Intestinal  lesions. 
This  was  carried out  In  five  Member  States,  covering  180  persons with 
precancerous  Intestinal  lesions  and  a  control  group  of  500  persons. 
The  aim  was  to  Identify  possible  links  between  dietary  habits  and  the 
appearance  of  precancerous  lesions.  The  work  was  coordinated  by  the 
ECP,  and  the  preliminary  results will  be  published  towards  the  end  of 
1990. 
h)  Intervention  study  of  the  anti-promoting  role  of  calcium.  Launched 
In  1989  by  the  University of  ~ottlngham  (United  ~lngdom),  this  study 
will  monitor  a  group  of  200  persons  with  coiorectal. adenomas  and  a 
200-strong  control  group  for  a  period  of  five  years.  Each  group  Is 
divided  l~to  ~wo subgroups,  one  of  which  receives  a  dally  supplement 
of  1.5  g  of  calcium,  whilst  the  other  does  not.  The  results will· be 
available  In  1994. - 9  -
Action  16;  peyelopment  of  nutritional  recommendations  against  cancer 
adapted  to each of  the categories of oart!cloants concerned 
Despite  the  numerous  uncertainties  affecting  current  knowledge  of  the 
1  1  nics  between  nut r 1  t 1  on  and  cancer,  the  European  CommIt tee  of  Cancer 
Experts  has  formulated  two  r~commendatlons on  nutrition,  Introduced  by  a 
general  warning: 
"Your  general  health  will  benefit  from  the  following  two  commandments 
"which  may  also  reduce  the  risks of  some  cancers: 
"Frequently  eat  fresh  fruits  and  vegetables  and  cereals  with  a  high 
"fibre content. 
"Avoid  becoming  overweight  and  1 lmlt  your  Intake of  fatty  foods." 
These  two  rules  have  been  pub! lclzed  by  the  governmental  and  non-
governmental  programme  participants  in  each  Member  State,'  In  most  cases 
with  f~nanclal  support  from  the  European  Commission. 
Action  17:  Harmonization  of  nutritional  labelling of  foodstuffs  In  the 
Eurooean  CommunitY 
The  European  Commission's  proposal  dated  5  October  1988  (COM  (88)  489 
final)  was  revised  following  consultation  of  the  European  Parliament 
(COM  (89)  420  final),  resulting  In  a  common  position  dated  21  December 
1989.  Article  2  of  this  common  position  states  that  "Nutrition 
label I log  shal I  be  compulsory  when  a  nutrition  cla.lm  Is  made  In 
labelling or  advertising.  Nutrition  la~elllng  Is  optional  In  all  other 
cases."  {OJ  No  C 66,  16.3.1990). 
Action  18;  Consumer  orotectlon against  certain agents  In  foodstuffs 
In  1988  the  European  Commission  drew  up  a  new  proposal  for  a  Directive 
on  pesticide  residues  In  fruit  and  vegetables  (OJ  No  C  46,  25.2.1989), 
on  the  basis  of  Article  43  of  the  EEC  Treaty.  This  consol !dates 
existing  legislation  and  In  addition  makes  It  compulsory  to  provide 
clear  Information  for  the  consumer.  The  Council  will  reach  a  decision 
on  this  proposal  once  the  European  Pari lament  has  del lvered  Its opinion 
at  the  May  1990  part-session. 
Act !on  19;  !moroyement  of  ex 1st log  !nformat lon  camoa!gns  concerning 
nutrition 
All  the  participants  In  the  "Europe  against  cancer"  programme  In  the 
twelve  Member  States  realigned  their  Information  campaigns  aimed  at  the 
genera I  pub II c  to  take  account  of  the  two  European  cancer  prevent !on 
rules  on  nutrition  and  the  results of  epidemiological  studies  which  had 
become  available.  New  brochures  were  pub! !shed  with  financial 
assistance  from  the  European  Commission,  Including  "Diet  and  cancer" 
from  the  UK  Health  Education  Authority,  "Eet  wljzer"  from  the 
Nederlandse  Kanker  Bestr!Jdlng  and  "100  recettes  sante"  from  the 
Association contra  le  Cancer  (Belgium). - 10  -
Action  20;  Initiation  of  Information  campaigns  for  rocomondod 
foodstuffs 
Numerous  campaigns  were  conducted,  particularly  during  European  Cancer 
Information  Year,  Including  the  free  distribution  of  fresh  fruit  and 
vegetables  through  non-governmental  associations  - In  Italy  during  the 
European  Cancer  Prevent lon  Week  In  May  1988,  and  In  Luxembourg  and 
Denmark  during  the  European  Week  In  October  1989. 
Action  21;  Promotion of aoproorlate  foodstuffs  and  technlaues 
Community-level  activities of  this nature  may  be  Included  In  the  second 
plan of  action,  1990-1994. 
Action  22;  Evaluation of pilot experiments  In  nutrition 
An  assessment  of  the  strategies used  to  provide  the  general  public  with 
nutrition  Information  and  education  was  started  In  1989,  and  the  results 
wl  I I  be  pub! lshed  In  1990. 
Action  23;  Exchange  of  Information on  "nutrition and  cancer• 
In  1988  and  1989  several  symposia  were  organized,  with  the  flna~nclal 
support  of  the  "Europe  against  cancer"  programme. 
a)  European  seminar  on  •fighting  cancer  with  prevention.  education  and 
research•  for  60  scientific  Journalists.  (Organized  by  the  European 
School  of Oncology.  Venice.  11-12 Uay  1989). 
Two  of  the  papers  dealt  with  nutrition,  namely  "Ingestion  of  fats  and 
the  risk of  cancer"  and  "Vegetable  fibres  and  the  risk  of  cancer".  AI  I 
the  papers  presented  are  available  In  a  booklet,  and  the  most  Important· 
ones  wll I  be  published  In  French  and  English  by  Springer  Verlag  In  mld-
1990. 
b)  EEC  workshop  on  the  Important  components  of  food  and nutrition pol Icy 
In  the  EEC.  (Organized  by  the  Athens  School  of  Public  Health  In  Corfu. 
6-8 October  1988). 
This  workshop  looked  at  current  knowledge  of  I Inks  between  nutrition  and 
health  and  examined  existing  legislation  on  foodstuffs,  especially 
nutritional  labelling.  The  proceedings  have  been  summarized  in  a 
brochure  (In  EnglIsh),  several  thousand  of  which  have  been  distributed. 
c)  EEC  workshop  on  recommended  dietary  Intakes.  (Organized  by  the 
Athens  School  of Public Health.  23-25  November  1989) . 
.  This  workshop  examined  the  similarities  and  differences  between  the 
dietary  Intakes  ·recommended  In  the  European  Community  Member  States  and 
Scandinavia.  The  objective  was  to  study  the  possibility  of  harmonizing 
the  nutritional  standards  recommended  In  Europe.  The  proceedings  have 
been  summarIzed  In  a  brochure  and  w  II 1 ·be  pub 1  1  shed  as  a  supp 1  ement  to 
the  European  Journal  of  Cl lnlcal  Nutrition  In  1990. 
*  * 
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Ill. PROJECTION  AGAINST  CARCINQGENIC  AGENTS 
Action  24;  protection  against  Ionizing  radiations  and  fo!IQW=UD  to 
Chernobvl 
On  14  December  1987  the  Council  adopted  Regulation  (Euratom)  No  2218/89 
laying  down  maximum  permitted  levels  of  radioactive  contamination  of 
foodstuffs  and  of  feedlngstuffs  following  a  nuclear  accident  or  any 
other  case  of  radiological  emergency  (OJ  No  L  371,  30.12.1987), 
Regulation  (EEC)  No  2219/89  on  the  conditions  governing  exports  of 
foodstuffs  and  of  feedlngstuffs  following  a  nuclear  accident  or  any 
other  case  of  radiological  emergency  (OJ  No  L  371,  30.12.1987),  and 
Directive  (Euratom)  No  618/89  on  Informing  the  population  of  health 
protection  measures  and  behaviour  In  the  case  of  a  radiological 
emergency  (OJ  No  L  371,  30.12.1987). 
Action  25;  Creation  of  an  observation  antenna  and  establishment  of  a 
list of chemical  substances  suspected of  being carcinogenic 
Owing  to  a  shortage  of  staff,  It  was  not  possible  to  create  such  an 
antenna  within  the  European  Commission.  However,  the  following  studies 
have  been  financed  under  the  "Europe  against  cancer~ programme; 
·a)  Study  of  occupational  cancers  among  workers  Involved  In  the 
manufacture  of  certain  types of  herbicides.  The  purpose  of  this  study, 
by  the  National  Institute  for  Public  Health  and  Protection  of  the 
EnvIronment  In  the  Nether I ands,  Is  to  compare  the  freQuency  of  deaths 
caused  by  the  various  types  of  cancer  among  persons  exposed  and  perso~s 
not  exposed  to  the  suspected  substances  (phenoxy  acids  and 
chlorophenols).  The  results  should  be  available  towards  the  end  of 
1990. 
b)  Study  of  the  carcinogenic  risks  of  certain  pesticides  used  In 
agriculture.  The  objective  of  this  case  control  study  Is  to  Identify 
the  possible  links  between  cancers  observed  among  certain  farmers  and 
chemicals  used  In  farming.  This  study  was  launched  In  1989  by  the 
Italian Health  Institute. 
c)  Preliminary study of  the  cancer  risk  among  biology  laboratory workers 
In  Europe.  The  need  for  such  a  study  became  apparent  In  1986  when 
several  cases  of  rare  cancers  occurred  at  the  lnstltut Paste4r  '"Paris. 
The  feaslbl llty study,  carried out  In  1988  and  1989  by  the  International 
Agency  for  Research  on  Cancer,  recommends  a  large-scale  European  study. 
d)  Pre llmlnary  study  of  the  prevent I on  of  secondary  cancers  ~aused  by 
chemotherapy.  This  study  Is  currently  being  carried  out  by  the 
International  Agency  for  Research  on  Cancer  and  alms  to  Identify  the 
possibilities  of  Improving  certain  types  of  chemotherapy  treatment  In 
order  to  reduce  the  long-term risks of  secondary  cancer. 
e)  Study  of  the  role  played  In  lung  cancer  by  exposure  to  radon  In 
houses  and  flats.  This  study  Is  currently  being  carried  out  by  the 
Department  of  Hygiene  and  Medicine  at  the  University of  Gent.  It may  be 
extended  to  France  and  the  Federal  Republ lc of  Germany. (JI 
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Act Jon  26:  Speeding  up  of  the  work  at  Community  !eye!.  and  creation of 
a  special  group  on  classification  and  labelling  of  carcinogenic 
substances 
In  1987  a  working  party  on  carcinogenic  substances  was  created  within 
the  "classification  and  label I lng  of  carcinogenic  substances"  group 
created  by  Directive 67/548/EEC.  several  suspected  substances  have  been 
exam 1  ned  durIng  the  past  three  years.  80  care I  nogen i c  substances  or 
groups  of  substances  have  already  been  classified,  and  at  the  beginning 
of  1990  a  further  150  substances.were  being  examined. 
Action  27;  Adoption  of  Qlrectlyes  currently  being  disCussed  by  the 
Councl I  for  the protection of workers 
On  9  June  1988  the  Counct 1  adopted  Directive  88/364/EEC  on  the 
protection of  workers  by  the  banning  of  certain  specified  agents  (OJ  No 
L  179,  9.7.1988).  Apart  from  a  number  of  exemptions  which  may  be  granted 
by  the  Member  States  for  clearly  specified  purposes  under  clearly 
established  conditions,  the  production  and  use  of  the  following 
substances,  responsible  for  cancers of  the  bladder,  are  banned: 
2-naphthylamlne  and  Its salts,  4-amlnobtphenyt  and  Its  salts,  benzidine 
and  Its salts,  and  ~-nltrodtphenyt.  The  Directive  also  states  that  the 
Councl I,  acting  by  a  qual !fled  majority  on  a  proposal  from  the 
Commission,  In  cooperation  with  the  European  Pari lament  and  after 
consu It I  ng  the  EconomIc  and  Soc I  a 1  Comm I t tee.  may  amend  the  Annex .  In 
particular  to  Include  further  agents or  activities. 
Action  28;  New  Plrectlyes  for  the  protection  of  workers  against 
carcinogenic substances 
On  21  December  1987  the  Commission,  acting on  the  basts of  Article  118  A 
of  the  EEC  Treaty,  presented  a  proposal  for  a  Councl I  Directive  on  the 
protection of  workers  from  the  risks  related  to  exposure  to  carcinogens 
at  work  (OJ  No  c  34,  8.2.1988).  Where  exposure  of  workers  Is 
inevitable,  the  proposal  cal Is  on  employers  to  take  various 
supplementary  measures,  Including  the  design  of  work  processes,  early 
detect ton  of  abnorma I  exposures,  1  nformat ion  for  workers,  surveIllance 
of  workers'  health,  emergency  measures,  and  arrangements  for  safe 
storage  of·  substances  and  safe  d 1  sposa I  of  waste.  The  EconomIc  and 
Social  Committee  delivered  Its  opinion  on  2  June  1988  (OJ  No  C  208, 
8.8.1988),  followed  on  24  May  1989  by  the  European  Parliament  (OJ  No 
C 158,  26.6.1989).  On  31  July  1989  the  European  Commission  transmitted 
to  the  Councl I  a  revised  proposal  taking  account  of  most  of  the  European 
Pari lament's  amendments  (OJ  No  C 229,  6.9.1989). 
On  30  November  1989  the  Council  of  Social  Affairs  adopted  a  common 
position  including  most  of  the  amendments  contained  In  this  latter 
proposal.  The  proposal  covers  52  chemical  agents  already  classified  as 
carcinogenic  and  wt  I I  automatically  be  extended  to  cover  any  substances 
classified as  such  In  the  future  (cf.  Action  26).  The  Directive  should 
be  adopted  finally  In  1990,  after  the  European  Part lament  has  given  Its 
opinion  on  the  Council's  common  position  at  the  part-session  In  May 
1990. - 13  -
Action  29:  prevention  of  occupational  cancers  by  rmoroy!ng  the 
oractlcal  organization  In  undertakings.  Including  Information  to 
employers  and  workers 
On  18  March  1988  the  Commission  presented  a  proposal  for  a  Council 
Directive  on  the  Introduction  of  measures  to  encourage  Improvements  In 
the  safety  and  health  of  workers  at  work  (COM  (87)  73  final).  It 
requires  employers  to  assess  the  health  risks -to  their  workers,  decide 
on  the  protective  measures  to  be  taken,  and  make  Information  accessible 
to  workers  and  their  representatives.  The  Directive  (EEC/89/391)  was 
adopted  In  June  1989  (OJ  No  L 183,  29.6.1989). 
Act I  on  30;  New  measures  for  oub I I  c  orot  ect I  on  agaInst  care I  nogen I  c 
substances 
On  28  January  1988  the  European  Commission,  acting  on  the  basis  of 
Article  100  A of  the  EEC  Treaty,  presented  to  the  Councl,l  a  proposal  for 
Directive  amending  Directive  76/769jEEC  relating  to  restrictions  on  the 
marketing  and  use of  certain dangerous  substances  and  preparations.  The 
substances  covered  Inc Jude  the  four  product  families  ment loned  under 
Action  27,  plus  benzene.  The  Directive was  adopted  by  the Councl I  on  21 
December  1989  (OJ  No  L 398,  30.12.1989). 
*  * 
* 
IV.  SYSTEMATIC  SCREENING  AND  EARLY  DIAGNOSIS 
-Action  31;  Promotion  of  a  pr!flcv  for  systematic  screening  and  early 
diagnosis of cancer of  the ute  =ne  cervix  and  cancer of  the breast 
In  1988  the  Committee  of  Cancer  Experts set  up  under  the  "Europe  against 
cancer"  programme  created  two  sub-committees  on  screening  for  breast 
cancer  and  cervical  cancer  respectively.  Each  of  these  sub-committees 
drew  up  a  str let  protocol  to  be  respected  by  a II  projects  to  be  taken 
under  the wing  of  and  receive  financial  support  from  the  "Europe  against 
cancer"  programme.  For  example,  systematic  screening  for  breast  cancer 
Is  recommended  between  the  ages  of  50  and  65  (every  2-3  years)  and  for 
cervical  cancer  ev~ry 3-5  year~ from  the  age  of  25. 
A  European  network  of  pilot  projects  for  breast  cancer  screening  was 
establ lshed  In  1989.  Every  project  must  monitor  a  group  of  at  least 
10  000  women,  each of  whom  must  be  Invited  by  a  personal  letter,  with  an 
automatic  reminder  If  necessary,  In  order  to  achieve  high  rates  of 
participation.  In  four  regions  - Plrgos  (Greece),  Navarra  (Spain), 
Porto  (Portugal)  and  Limburg  (Belgium)  -mobile  units  are  used  for 
screening.  In  the  Dublin  area  screening  takes  place  In  a  mobile  unit 
and  at  a  permanent  centre  (Mater  Hosp ita 1).  1  n  the  Department  of  Bas-
Rhtn  (France),  It  Is  done  by  approved  radiologists.  In  1990  the  network 
wi'IJ  be  extended  to  the  Florence  region  and  to  Luxembourg.  The  staff 
Involved  In  pilot  operations  are  being  Invited  for  further  training  at 
one  of  the  most  advanced  screenIng  centres,  · that·  In  Utrecht 
(Netherlands). - 14  -
Finally,  the  "Europe  against  cancer"  programme  budget  permitting,  a 
start  could  be  made  In  1991  on  setting  up  a  European  network  of  pi lot 
proJects  for  cervical  cancer  screening. 
Action  32:  Eyaluotlon  and  lmoroyement  of  the  policy  for  tho  systematic 
screening and  early dlognosls of other  common  cancers 
There  are still  many  uncertainties  about  the  usefulness of  policies  for 
systematic screening  for  colorectal  cancers  by  detection of  blood  In  the 
faeces,  which  Is  why  the  "Europe  against  cancer"  programme  has  not  given 
financial  support  to  the  many  projects  submitted.  On  the  other  hand, 
three  studies on  the  subject  have  been  financed  under  the  first  plan  of 
action  1987-1989: 
a)  A  report  on  the  efficiency  of  hemocutture  for  early  detection  of 
colorectal  cancers.  Carried  out  by  experts  of  International  standing 
under  Professor  Hardcastle  {United  Kingdom),  this study was  described  at 
the  European  Conference  In  Venice  on  11-12  May  1989.  Publication  In 
French  and  English  by  Springer  Verlag  will  follow  In  1990  (cf.  Action 
23). 
b)  A study  to  assess  the  efficiency  of  colorectal  cancer  screening  In 
the  Federal  Republic  o~  Germany.  Conducted  In  the  Saarland  by  the 
University  of  Heidelberg,  It  wl  I I  provide  an  assessment  of  the 
effectiveness of  colorectal  cancer  screening,  which  was  Introduced  on  a 
large  scale  In  1977.  The  results should  be  aval table early  In  1991. 
c)  A  controlled  experiment  on  the  efficiency  of  colorectal  cancer 
screening  In  the  Dljon  region  (France).  This  experiment,  comparable  In 
principle  with. those  carried  out  In  the  United  Kingdom  and  Denmark, 
covers  45  000  persons  aged  between  47  and  55.  Initial  results should  be 
available as  from  1991. 
*  * 
* 
V.  "EUROPEAN  CODE  AGAINST  CANCER• 
Action  33:  Transformation  Into  layman's  language  of  the  Eurooean  Qode 
Against  Cancer 
The  European  Code  Against  Cancer  was  adopted  by  the  Committee  of  Cancer 
Experts  set  up  under  the  "Europe  against  cancer"  programme  In  May  1987 
following  wide  consultation  of  the  health  ministries  and  non-
governmental  organizations  Involved  In  the  fight  against  cancer. - 15  -
CHAPTER  2;  INFORMATION  AND  HEALTH  EDUCATION 
I.  INFORMING  THE  GENERAL  PUBLIC 
Action  34:  Establishment  of  a  directory  of  the  or!yate  organizations 
against  cancer  In  Eurooe 
This  d~roctory was  prepared  In  1987  and  Is  aval !able  In  French,  English 
and  German.  It  will  be  updated  In  1990. 
Act I  on  35:  COmoar at 1  yo  sur  yey  of  or 1  yate  and  pub I 1  c  cancer  prevent I  on· 
Information campaigns 
At  tho  start  of  the  plan  of  action  1987-1989,  a  general  study  was 
undertaken  to establish what  had  been  accompl !shed  In  tho  various  Member 
States.  The  creation  of  the  group  of. organizations  against  cancer  led 
to  a  broad exchange  of  experience  and  permitted  continuous  assessment  of 
actions  (dissemination  of  the  European  Code  through  various  channels, 
organization  of  open  days,  travel I log  exhibitions,  etc.)  On  25  January 
1990  a  symposium  was  held  In  Athens  to  assess  the  efficiency  of  actions 
(cf.  special  report  on  the  European  Cancer  Information Year). 
Action  36;  Bringing  cancer  prevention  and  the  ueurope  against  cancer" 
Programme  to the attention of  the media 
Following  an  Invitation  to  tender,  a  pub!  lc  relations  agency  network  was 
set  up  at  the  beginning  of  1987,  and  as  from  1989  a  "Europe  against 
cancer"  programme  correspondent  was  assIgned  to  each  of  the  European 
Commission's  offices  In  the  Member  States.  Every  year  two  press 
conferences  are  organized  simultaneously  In  the  twelve  Member  States, 
and  three  or  four  press  releases  are  sent  out.  In  some  countries  (e.g. 
Denmark)  the  press  reI eases  have,  s I  nee  1989,  been  backed  up  by  a 
bimonthly  newsletter.  This  will  be  practised  in  all  countries  as  from 
1990. 
Action  37; ·  Eurobarometor  suryoy  of  Europeans'  attitudes  to  cancer  and 
Its prevention 
Between  1987  and  1989 several  surveys  were  carried out  simultaneously  In 
the  twelve  Member  States of  the  European  Community  to  assess  the  extent 
of  knowledge  and  application  of  the  European  Code  Against  Cancer  by  the 
general  public,  doctors  and  teachers.  The  survey  reports  are  aval lable 
In  French  and  EngJ  Ish,  and  a  book  containing  the  full  results  will  be 
pub I I  shed  In  French,· Eng I 1  sh  and  German  towards  the  end  of  1990. 
Action  38;  Financial  contribution  to  teleylslon  cancer  prevention 
broadcasts for  the general  pybllc 
Ten  television  programmes  on  cancer  prevention  and  treatment  were 
financed  In  1988  and  1989  by  the  "Europe  against  cancer"  programme.  Two 
of  them  received  International  awards.  The  European  Cancer  lnforma~lon 
Year  ended  on  9  January  1990  with  a  major  Eurovlslon  broadcast  (cf. 
special  report  on  the  European  Year). - 16  -
Action  39:  Plssemlnatlon of  the  Eurooean  Code  Against  Cancer  at  soorts 
and  cultural  events sponsored  by  the European  community 
Two  of  these  events  deserve  special  mention.  First  of  alI  the  special 
concerts  given  In  1987  to  mark  the  30th  anniversary  of  the  Treaty  of 
Rome,  when  around  100  000  ECU  was  collected  and  donated  to  the  European 
Organization  for  Research  on  Treatment  of  Cancer.  Secondly,  the  1989 
Tour  de  France  across  Luxembourg,  Belgium  and  France,  when  the  "Europe 
against  cancer"  programme  was  represented  In  the  accompanying  convoy  by 
two  vehicles  In  the  programme  colours,  which  distributed  Information  In 
several  languages  on  the  Europein  Code  Against  Cancer.  This  action  was 
coordinated by  a  Netherlands  anti-cancer  association,  the  LOK. 
Action  40:  public  meeting  to  mark  the  end  of  the  first  year  of  the 
•eyrope against  cancer•  Programme 
Our I  ng  the  European  Counc I I  In  Copenhagen  on  5  December  1987,  a  br I  e f 
official  ceremony  was  held,  and  a  prestige  version of  the  European  Code 
Against  Cancer  was  presented  to  the  Danish  Prime  Minister,  the 
President-In-Office  of  the  Council.  Each  Head  of  State  and  Government 
received  a  similar  copy  In  his or  her  own  language. 
Action  41:  PreParation  of  the  actions  to  be  carried  out  In  1989.· 
•european Cancer  Information year" 
This  Involved  th·e  various  networks  of  partners  set  up  since  the  end  of 
1986:  cancer  prevention,  anti-smoking  and  general  practitioners' 
organizations;  producers  of  medical  programmes  for  the  European 
television  stations;  pub! lc  relations  agencies;  senior  health  and 
education  ministry  officials.  A  total  of  nearly  100  non-governmental 
organizations  took  part. 
Action  42:  Organization of  a  European  week  against  cancer  as a  test  for 
tho  1989  campaign  <European  Cancer  Information  Year> 
The  purpose  of  this  week  (1-8  May  1988)  was  to  prepare  for  the  European 
Cancer  Information  Year.  Three  European  television  broadcasts  were 
produced  by  the  European  Commission,  and  numerous  activities  were 
organized  by  the programme  participants. 
Act I  on  43:  I  ncroaso  In  1988  of  the  campaIgns  carr led  out  In  1987  to 
Inform  tho  oybllc  and  Increase  Public  awareness  of  tho  campaign  against 
cancer 
The  objective  was  achieved  despite  a  very  limited  budget,  thanks  above 
an·  to  the  non-governmental  organizations,  which  Invested  substantial 
human  and  financial  resources  In  the  dissemination  of  the  European  Code 
Against  Cancer.  Polls  In  the  twelve  Member  States  measured  changes  In 
the  degree of  awareness  of  this Code,  and  the  excellent  results  recorded 
In  certain  southern  European  countries  show  t·hat  It  Is  possible  to 
Increase  Europeans'  awareness  on  matters of  such  paramount  Importance  as 
their  health. - 17  -
Action  44;  Interesting  teachers  and  the  health  professions  In 
dissemination of  the  Eurooean  cancer  Prevention commandments 
The  European  Commission  was  able  to  Involve  these  vital  groups  despite  a 
lack  of  financial  resources,  thanks  to  the  representatives  of  general 
practitioners  and  senior  health  education  officials  whom  It  met  twice  a 
·year  In  Brussels.  In  many  countries  the  European  Code  Against  Cancer 
was  displayed  In  general  practitioners'  waiting-rooms,  and  there  were 
numerous  campaigns  aimed  at  schools  (cf.  special  report  on  the  European 
Year). 
Action  45:  Organization  In  1989  of  a  media  campaign  aimed  at  the 
gerieral  pub! lc:  •12 nations.  12  days of  action against  cancer• 
This  action was  not  carried out  owing  to a  lack  of  funds. 
Action  46;  Intensification  In  1989  of  the  campaigns  carried oyt  In  1987 
and  1988  to ·Jnform  the pyb lie and  Increase  pyb lie awareness of  the  f lght 
against  cancer 
See  special  report  on  the  European  Cancer  Information  Year.  The  table 
next  page  Illustrates  the  encouraging  results  reached  In  most  of  the 
Member  States. 
*  * 
* 
I I •  HEALTH  EPUCAJ I  ON 
Action  47:  Establishment  of  a  comparative  syryey  of  health  ·education 
programmes  In  Eurooean  schools 
Two  comparative  studies of  health  education  In  the  twelve  Member  States 
of  the  European  Community  were  carried out  In  1988  and  1989.  The  first, 
by  Professor  Trevor  Will lam  (Head  of  the  Health  Education  Department  at 
the  University  of  Southamptom  and  consultant  to  the  "Europe  against 
cancer"  programme)  looked  at  the  existing  situation.  The  second  took 
the  form  of  a  survey  of  2  750  teachers  In  the  European  Community.  Both 
studies,  together  with  other  reports,  were  presented  at  the  first 
European  conference  on  "Health  education  and  cancer  prevention  In 
schools",  held  In  Dublin  on  7-9  February  1990,  the  proceedings of  which 
wl  I I  be  pub! !shed  In  the  nine  official  languages  of  the  European 
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EVOLUTION  OF  THE  NOTORIETY  OF  THE  EUROPEAN  CODE  DURING  THE 
EUROPEAN  YEAR  OF  INFORMATION  ON  CANCER 
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The  objective  of  the  "European  Year  of  Information  on  Cancer" 
was  to  increase  the  notoriety  of  the  "European  Code  against 
Cancer".  This  objective  was  attained  in  nine  of  the  twelve 
countries,  and  most  spectacul~rly  in  Portugal  (from  29%  to 
56%).  On  the  contrary,  in  the  Netherlands  and  the  United 
Kingdom  the  level  of  notoriety  remained  stationary  and  fell 
slightly in  Germany  (from  15%  to  12%)  and  in  Denmark  (from  15% 
to  11%). - 18  -
Action  48:  Drawlng-uo  of  oroposats  to  Improve  health  education 
orogrammes  In  schools 
On  31  May  1988  the  Council  and  Health  Ministers,  meeting  within  the 
Counci 1,  adopted  a  Decision  on  a  plan  of  action  for  1988-1989  on 
Information  and  health  education  in  the  context  of  the  "Europe  against 
cancer"  programme  (OJ  No  L  160,  26.6.1988).  On  23  November:  1988  the 
Councl 1  and  Education  Ministers,  meeting  within  the  Councl I,  adopted  a 
general  resolution  on  health  education  In  schools.  Finally,  on 
13  November  1989,  the  Councl I  and  Health  Ministers,  meeting  within  the 
Council,  adopted  In  principle  - whilst  awaiting  the  opinion  of  ·the 
European  Parliament- a  Decision  on  the  second  plan  of  action  1990-1994 
under  the  "Europe  against  cancer"  programme.  The  planned  health 
education  campaigns  aimed  at  preventing  cancer  will  benefit  from  a 
budget  averaging close  to  2  mil I ton  ECU  per  annum. 
Action  49:  proy!slon of  teaching material  relating  to health education 
Three  types  of  European  audio-visual  material  were  produced  by  the 
European  Commission  In  the  nine  official  languages  of  the  European 
CommunitY  and  distributed  free  of  charge  via  the  governmental  and  non-
governmental  programme  participants: 
a  booklet  aimed  at  the  general  publ  I~  about  the  "Europe  against 
cancer"  programme; 
a  set  of  six  posters  containing  the  European  Code  Against  Cancer  and 
five  maps  showing  cancer  deaths  in  Europe  (lung-tobacco;  oesophagus-
alcohol;  melanomas-sun;  stomach-fruit  and  vegetables;  breast-fats); 
a  cartoon  video  for  children  ("Euro-Jim  against  Crab  Cancer"), 
I I lustratlng  the  European  c~mmandments  relating  to  tobacco.  alcohol, 
sun,  fruit  and  vegetables,  and  fats)  and  two  fl lms  for  older 
teenagers  and  adults  ("Man  and  cancer"  and  "Lifestyle  and  cancer  In 
Europe"). 
Action 50:  Contribution  to  the  financing of  teleylslon health education 
broadcasts on  the oreyentlon and  treatment  of  cancer 
In  addition  to  the  television programmes  aimed  at  the  general  public  and 
mentioned  under  Action  38,  the  European  Commission  produced  a  special 
health  education  fl lm  entitled  "Prevention  and  early  detection  of 
cancer",  which  was  awarded  the.first  prize  for  fl lms  on  cancer  at  the 
International  medical  film  festival  In  Parma  (Italy)  In  1989.  This  film 
Is  particularly  suitable  for  health  education  teachers  and  will  be 
aval table  on  video  to  programme  participants  free  of  charge  as  from  mld-
1990. 
*  * 
* .- 19  -
CHAPTER  3:  TRAINING  OF  THE  HEALTH  PROFESSIONS 
Action  51:  comoaratlye  study of  the  systems  of  ynlyerslty  training  for 
health  care workers 
On  the  basis  of  the  general  recommendations  drawn  up  In  1986  by  the 
Committee  of  Cancer  Experts  set  up  under  the  "Europe  against  cancer" 
programme  and  specific  reports  by  four  European  experts  In  1987,  the 
three  Advisory  Committees  on  the  training  of  nurses,  dentists  and 
doctors  de I I  vered  theIr  opInIons  and  recommenda t Ions  In  1988  and  1989 
(documents  II  I  /D/248/3/88  of  20  December  1988,  I I I  /D/886/3/88  of 
22  November  1988,  111/D/890/3/89  of  20  Apr II  1989).  These  opinions  and 
recommendations  were  sent  officially  to, the  Member  States'  Ambassadors 
(Permanent  Representatives)  In  1989  to  ensure  maximum  pub! lclty. 
On  8  November  1989  the  European  C?mmlsslon  formally  adopted  a 
Recommendation  concerning  the  training of  health  personnel  In  the matter 
of  cancer.  It  "recommends  that  the  Member  States,  their  competent 
authorities  and  their  establishments  responsible  for  professional 
training  make  every  effort  to  ensure,  In  accordance  with  their 
respective  competence,  that  [the  recommendations  of  the  three  Advisory 
Committees  on  the  training of  health  personnel]  are  widely  distributed, 
discussed  and  Implemented".  (OJ  No  L 346,  27.11.1989). 
Action  52:  Formulation  of  proposals  for  Improving  the  organization  of 
studies  In  the  cancer  field 
In  May  1988  a  first  European  conference  on  cancer  training  as  part.of 
basic  medical  studies  was  held  In  Bonn.  Organized  Jointly  by  the 
European  Commission  and  ~he  European  0r9anlzatlon  for  Research  on 
Treatment  of  Cancer,  It  was  attended  by  around  40  faculty  of  medicine 
deans  and  cancer  experts.  Consensus  was  reached  on  the  minimum  amount 
of  cancer  traInIng  In  bas 1  c  med 1  ca 1  studIes  and  on  the  procedures  for 
Implementation.  Three  further  "consensus"  conferences of  this  type  were 
prepared  In  1989,  covering  cancer  training  for  dentists,  nurses  and 
general  practitioners. 
Action 53;  Stimulation of mobility of  medical  and  nursing students 
50  grants  were  awarded  In  1989  to  doctors  and  nurses  wishing  to  undergo 
further  training  In  cancer  at  'the  European  School  of  Oncology  In  Venice. 
Another  20  grants  were  awarded  In  1989  to  persons  Involved  In  the 
European  network  of  pilot  projects  for  breast  cancer  screening  to  allow 
them  to  receive  further:  training  at  the  Prevention  Centre  In  Utrecht. 
Grants  were  also  awardeq  to  medical  students  and  student  nurses  under 
the  ERASMUS  programme. 
Action  54;  Joint  oreoaratlon  and  exchange  of  teaching  materials  and 
testing of this during  the  European  Cancer  Information Year 
Teams  of  International  experts  prepared  handbooks  for  the  European 
School  of  Oncology  on  lung  cancer  (1988)  and  breast  cancer  (1989)  to  be 
used  for  Initial  or  further  training  of  general  practitioners.  These 
were  distributed  to  a  sample  of  general  practitioners  for  trial  use  and 
wl  I I  be  published  as  from  September  19~0  In  the  nine  official  languages 
of  the  European  Community,  by  Springer  Verlag. - 20-
Action 55;  Exchange  of exPerience on  contlnuoys  training 
The  European  Commlsslor:t  has  limited  Its  activity  In  this  field  to 
further  training  for  general·practitloners,  given  their  central  role  In 
a  pol Icy  of  cancer  prevention  and  screening.  Apart  from  the  handbooks 
mentioned  above,  an  ad-hoc  working  party  was  set  up  to  prepare  the 
consensus  conference  on  the  tralnlng  of  general  practrtloners,  which 
should  take  place early  In  1991. 
Action  56;  Development  of  common  computer  programs  for  exoert  medical 
systems  for  cancer 
This  action  was  not  carried out  owing  to  lack  of  funds. 
*  * 
* - 21  -
CHAPTER  1  CANCER  RESEARCH 
Act Iori  57  European  grants  to  encourage  mob Ill ty  of  cancer  research 
workers 
The  cancer  research  training  scheme  became  fully  operat lonaJ- In  1988. 
More  than  one  hundred  fellowshIps  were  a !located  to  young  scIentIsts 
wanting  to  spend  up  to  two  years  in  another  Member  State,  or  In 
Switzerland  or  Austria  (countries  participating  In  the  cancer  target). 
In  1988  25  post-doctoral  and  21  post-graduate  long-term  fel lowshlps  were 
allocated  (for  one  year  and,  In  exceptional  cases,  two  years). 
Moreover,  10  short-term  fellowships  were  allocated  (up  to  four  months). 
In  1989  21  post-doctoral  and  17  post-graduate  long-term  fel lowshlps  as 
wei  I  as  18  short-term fel lowshlps  were  a!  located. 
Action  58  ;  Comoarlson  of  existing  cancer  registers  and  recommendation 
for  thelr·mln!mym  contents and  conditions of  access  to  them 
During  the  first  action  plan  a  study  was  carried  out  by  the 
International  Agency  for  Research  on  Cancer  (!ARC)  In  Lyon  on  the 
existing  cancer  registries  In  Europe.  This  study  shows  several 
different  approaches  towards  data  col lectlon and  data  management. 
In  1989  the  first  phase  of  a  feasabl 1 ity  study  for  setting up  a  European 
Network  of  Cancer  Registries  was  carried  out,  coordinated  by  the  !ARC 
and  the  Danish  Cancer  Registry.  The  aim  of  the  study  Is  to  fix  a 
minimum  of  data  collection  In  order  to  enhance  comparability.  During 
the  second  action  plan  1990-1994,  this  network  will  be  set  up  and 
gradually  be  extended  to  permit  the  implementation  of  a  monitoring 
system on  cancer  Incidence  In  the  EC. 
Action  59  ;  launching  European  coordination of  medical  research  on  food 
and  cancer 
This  action,  which  Is  partially  under  way  within  the  framework  of  the 
joint  EURONUT-ECP  (European  Organization  for  Cooperation  In  Cancer 
Prevention  Studies)  project,  has  seen  the  launching  of  a  pi lot  study  on 
the  role  of  dietary  factors  In  the  development  of  type  B  atrophic 
gastritis,  a  pre-cancerous  stomach  lesion.  Data  are  collected  In  seven 
countries  and  In  a  few  months  the  centres will  stop collecting cases  and 
controls.  The  next  s'tep  Is  the  data  set  analysis.  The  total  number  of 
c~ses and  contro'ls will  be  around  450  Instead of  the  planned 600. 
A col laboratlve  research  project  on  the  geographic  correlation  between 
biological  risk  factors  for  gastritis  ~nd  gastric  cancer  has  been 
financed  by  the  Commission  from  January  1989  for  a  period of  two  years.  ' 
A  first  meeting,  organized  In  col laboratlon  with  the  International 
Agency  for  Research  on  Cancer  (!ARC)  In  Lyon,  permitted  the  finalization 
of  the  study protocol. - 22  -
Action 60  ;  Steootng-up of  European  Research  on  occupational  can~ers 
Following  up  a  seminar  held  In  Paris  in  December  1987  on  methodologies 
for  evaluating  the  1 Inks  between  occupational  exposure  and  the  risk  of 
~eveloplng cancer,  a  workshop  was  organized  in  1988  to  prepare  a  joint 
action  on  this  subject  within  the  framework  of  the  fourth  Medical  and 
Health  Research  Programme  (1987-1991}.  A  proposal  for  a  concerted 
act I  on  was  approved  In  ·June  1989  and  w  I I I  be  f I  nanced  by  the  Comrn Iss I  on 
from  January  1990  onwards  for  a  duration of  2  1/2  years. 
The  objectives of  the  concerted action  are 
1.  to  Improve  the  ways  of  measuring  occupational  exposures  In 
epidemiological  Investigation of  cancer; 
2.  to  compare  the  performance  of  different  methods  on  a  large  number  of 
epidemiological  surveys  In  a  standardized  way,  to  make  conclusions 
and  recommendations. 
Action  61  ;  Continuation  of  the  co-financing  bY  the  Eurooean  Community 
of  research on  the 'oreyentlon of  radiation-Induced cancers 
The  current  (1985~1989)  and  future  (1990-1991)  Radiation  Protection 
Research  Programmes  support,  on  a  cost-shared  basis,  projects  designed 
to  Improve  the understanding of  how  radiation  induces  cancer  and  what  Is 
the  dependence  on  dose  and  exposure  conditions. 
1.  Cell  transformation  and  molecular  biology  studies  Investigate  the 
mechanisms  by  which  radiation converts  a  normal  cell  to malignancy. 
2.  Animal  studies  Investigate  the  effect  of  dose,  dose  rate  anq 
radiation  qual lty on  the  Induction of  cancer. 
3.  Epidemiological  studies  on  human  populations  exposed  to  Radium  and 
Thorotrast  In  previous  medical  treatments  and  to  Radon  "In  homE!s 
attempt  to  determine  the  risk  of  cancer  Induction  from  these  sources 
of  radiation. 
A meeting  on  "Cel I  transformation  systems  relevant  to  radiation-Induced 
cancer  !n  man"  was  J9lntly  organized  by  the  Commission,  the  US 
Department  of  Energy·  and  the  Nuclear  Energy  Board  of  Ireland,  and  the 
proceedings  of  the  meeting  have  been  published.  A  report  "Feasabl llty 
of  StudIes  on  Hea It h  Effects  In  Western  Europe  due  to  the  Reactor 
Accident  at  C~ernobyl  and  Recommeridations  tor  Research"  has  been 
finalized.  The·  report  concludes  that  It  will  be  virtual iy  Impossible  to 
detect  the  relatively  few  cancers  resulting  from  the  accident  but 
recommends  that  an  epidemiological  study of  childhood  leukemia  Incidence 
be  made  using existing cancer  registries. - 23  -
Action  62  ;  Continuation  of  co-flnancina  by  the  Eurooean  COI!IDunlty  of 
research on  environmental  factors  and  cancer 
The  coordinated  projects  In  this  area  are  Intended  to  provide  a 
scientific basis  for  early  Identification and  assessment  of  cancer  risks 
to  the  general  population  from  environmental  factors.  There  are  a 
number  of  substantial  projects currently  under  way 
1.  Genetic  effects  of  environmental  chemicals,  which  Include  the 
following  research  topics  : 
Mechanisms  of  mutagenesis; 
-Quantitative mutagenesis  (molecular  dosimetry); 
-Development  and  validation of  predictive  tests  for  chromosome  non-
disjunction; 
-Development  and  validation  of  tests  for  detection  of  epigenetic 
(promoter)  substances. 
2.  Blomonltoring  of  human  populations  exposed  to genotoxlc environmental 
chemicals  the  aim  of  this  project  Is_  to  develop  monitoring 
techniques  fQr  the  determination  of  chemical ly-lnduced  DNA  damage  In 
man. 
3.  The  EC  environmental  R & D Programme  has  been  requested  by  the  OECD 
to  prepare  a  review  of  the  OECD  guidelines  for  Genetic  Toxicity 
tests. 
Action 63  :  Continuation of  Eurooean  coordination of  medical  research on 
cancer  and  reorodyctlon 
In  1988  two  studies  were  carried  out  as  a  part  of  the  EUROCAT  Project 
for  birth  survel I lance  In  order  to  assess  the  mutagenic  and  teratogenic 
consequences  of  the  Chernobyl  accident.  The  preliminary  results  do  not 
suggest_ an  Increase  In  frequency  of  chromosomal  syndromes  or  of  central 
nervous  system  anomal les  among  conceptuses  In  women  exposed  to  radiation 
In  May-August  1986.  The  results  have  been  pub I I  shed  (De  Wals  P.  et al., 
Int.  J.  Epldemlol.  17:  230-231,  1988;  EUROCAT  Working  Group,  Paed. 
Perlnat.  Epldemlol.  45:369-382,  1988).  A  re-analysis  of  the  data 
collected  In  1988  and  1989  Is  foreseen. 
Other  studies  are  needed  to  assess  the  long-term  carcinogenic  effect  of 
the  contamination. 
Action  64  ;  Launching  of  Eurooean  coordination  of  medical  research  on 
nasslye smoking 
A seminar  on  "Passive  smoking  and  health"  was  held  from  30  November  to 
1  December  1987.  On  the  basis  of  the  pQrtlcipants'  recommendations,  a 
proposal  for  a  project  on  the  effects  of  passive  smoklng'on  health  was 
submitted  to  the  Commission  for  examination. 
The  objectives of  the  concerted action  are 
to  estimate  the  overal I  Impact  of  passive  smoking  ~n  the  EC 
population; 
to substantiate and  quantify  the  effects of  exposure  to environmental 
tobacco  smoke  on  the occurence of  lung  cancer. 
This  proposal  has  been  approved,  and  has  been  financed  from  January  1989 
by  the  EC  for ·a  duration of  2  1/2 years. - 24  -
Action 65  ;  Continuation of  Euronean  coordination of medical  research on 
automated  tissue analysis 
1.  The  first  proJect  relates  to  cl lnically-appl led  analytical  cytometry. 
A  new  propos  a 1  has  been  approved  In  November  1988,  wIth  two  rna In 
lines.  The  first  one  Is  the  further  development,  adaptation  to  the 
users,  and  clinical  and  technical  evaluation  of  devices  for 
automated,  quantitative  and  analytical  cytology  and  histology;  the 
second  one  Is  directly  relevant  to  cancer.  In  part lcular  breast 
cancer,  with  multlcentre  clinical  studies  on  the  use  of  cytometrlc 
analysis  on  cytological  and  h_lstologlcal  specimens  for  early 
detection,  diagnosis,  prognosis,  and  treatment  management. 
Several  Instruments  have  been  developed  by  Industries,  In 
collaboration  with  participants  In  the  previous  concerted  action; 
they  are  In  the  phase  of  prototype  development  for  cl lnlcal  testing. 
It  Is  now  planned  to  participate,  In  particular,  In  screening 
programmes  for  cervical  cancer  using  automated  pre-screening  systems. 
2.  the  second  project  relates  to  automation  of  cytogenetics.  The 
progress  achieved  so  far  is  presented  in  a  publication  entitled 
"Automat ion  of  CytogenetIcs  - Advances  in  Systems  and  TechnIques" 
(Springer,  1989).  This  Includes  the  evaluation  of  complete  Image-
based  chromosome  analysis,  the  development  of  new  Image  techniques 
and  of  systems  for  chromosome  aberration  scoring,  automatic  specimen 
preparation,  and  the  use  of  flow  systems  for  chromosome  measurement 
and  analysis. 
Act I on  66  continued  Eyrooean  coordination  of  research  on  Imaging  In 
medicine 
A  new  project  on  Tissue  Characterization  by  Magnetic  Resonance 
Spectroscopy  (MRS)  and  Imaging  (MRI)  was  approved  :1n  June.  191?8.  Its 
main  objectives  are,  on  the  one  hand,  to  extend  the  scope  and  usage  of 
standardized  methods  In  the  fields  of  MRS  tissue  characterization  by 
Nuclear  Magnetic  Resonance  (NMR)  and  of  performance  assessment  of  MRS 
and  MRI;  and,  on  the  other  hand,  to  gather  more  complete  and  reliable 
data on  Magnetic  Resonance  properties of  tissues. 
It  fo I lows  a  project  on  I  dent If i cat I  on  and  character I zat !on  of 
biological  tissues  by  NMR  which  Included  works  on  NMR  standardization, 
methodology  for  In  vitro  measurement  of  relaxation  times,  test 
substances  for  cal lbratlon,  test  procedures  and  test  objects,  etc.  The 
activities  and  results  are  reported  in  a  series  of  six  papers  In 
Magnetic  Resonance  Imaging,  vol.  6,  n·2,  1988,  pp  173-222.  List  of  the 
activities held  In  1989  : 
1.  Workshop  on  "The  uses  of  an  1  n-v 1  vo  NMR  reI ax at ion  tIme  data  bank  -
Acquisition  and  accumulation",  Dundee,  13-15  March  1989; 
2.  Workshop  on  "Quantltatlon  In  NMR  spectroscopy  and  Its  medical 
lmpl !cations",  Rome,  16-17  June  1988. - 25  -
Another  project  was  approved  In  November  1988  on  Positron  Emission 
Tomography  (PET)  In  Investigation  of  Cellular  Regeneration  and 
Degeneration.  Its  main  objective  Is  to  Improve  the  understanding  of 
major  diseases  and  the  follow-up  of  treatment,  PET  being  the only method 
allowing non-traumatic estimation of  eel I  degeneration,  regeneration  and 
prot Iteration,  and  special  attention  Is  envisaged  .to  be  given  to 
pharmacology  since  PET  allows  pharmacol<lnetlc  studies,  estimation  of 
Interaction  of  drugs  with  their  specific  receptors,  and  consequently 
Improvement  In  drug  design  and  administration.  List  of  activities  In 
1989  : 
1.  First  model  I lng  expert  panel  meeting,  London,  13-14  Apr I I  1989; 
2.  First  radiochemistry workshop,  JUI  ich,  11-12  May  1989; 
3.  First  cardiology workshop,  Ptsa,  22-23  May  1989; 
4.  Oncology  symposium  & workshop,  London,  6-7  July  1989. 
Action  67  Strengthening  of  European  coordination  of  research  on 
cl Jnlca!  treatment  and  of  control  of  multi-centre  therapeutic trials 
1.  Under  the  fourth  Medical  and  Health  Research  Programme,  support  for 
the  EORTC,  as  well  as  for  Its  data  centre,  has  been  reinforced. 
Moreover,  the  Improvement  of  the  Eurocode  Informatics  network,  which 
facilitates  direct  communication  between  oncologists  and  their 
participation  In  the  EORTC's  clinical  trials,  has  been  achieved  by 
Instal I lng  peripheral  nodes  In  Britain,  France  and  the  Netherlands. 
2.  It  was  agreed  to  make  use  of  the  High  Flux  Reactor  at  Petten  (EC 
Joint  Research  Centre,  Netherlands)  to  establIsh  a  centre  for 
treatment  of  mal lgnant  brain  tumours  by  Boron  Neutron  Capture 
Therapy.  For  reasons  not  yet  fully  understood,  boron  compounds  are 
selectively accumulated  In  tumour  eel Is.  Subsequent  Irradiation with 
neutrons  results  In  the  capture  of  neutrons  by  the  boron  atoms, 
giving  rise  to  alpha-particles.  These  have  a  high  cell-destructing 
capacity  and  do  not  leave  the  tumour  since  they  move  only  5 
mlcrometres  In  tissue.  The  results  obtained  In  Japan  with  this 
treatment  are  promising.  A concerted action  was  approved  and  started 
In  July  1989.  Abvout  30  Institutes  wl  1 I  assure  the  scientific 
backing  of  the  treatment  facll ity  under  construction  at  Petten.  It 
Is  expected  that  the  first  patients can  be  treated  In  early 1992. 
3.  There  are  both  b to log I  ca I  as  we 1 1  as  phys I  ca I  reasons  to  assume  a 
potential  value  of  I lght  ion  beam  therapy  for  cancer.  Light  Jon  beam 
treatment  allows  a  more  accurate  Irradiation of  the  tumours,  thereby 
preserving·  the  surrounding  healthy  tissue.  The  cl lnical  trials 
performed  In  the  U.S.A.  so  far  indicate  that  there  Is  a  clear  value 
for  this  type  of  treatment  for  certain  tumour  types.  A  feaslbi I tty 
study  to  Investigate  the  possibi llty  of  installing  a  light  ion 
medical  accelerator  In  Europe  started  In  1988.  A  final  report  Is 
expected at  the  end  of  1991. 
4.  A concerted  action  on  the  role  of  cell  surface  properties  and  tumour 
specific antigens  In  metastasis  and  host  Immune  response was  approved 
and  started  In  July  1989. - 26  -
The  general  aim  Is  to  Improve  knowledge  of  the  tumour  eel I  properties 
that  Influence  the  specific  immune  response  of  the  host  and  the 
ability  of  tumour  eel Is  to  invade  surrounding  tissues  and  to 
metastasize,  In  order  to  develop  new  forms  of  cancer  treatment  by 
Increasing  the  specific  host  Immune  response  and  by  Inhibiting  the 
Invasive  potential  of  tumour  eel Is. 
5.  A  concerted  action  on  treatment  of  haematologlcal  malignancies  by 
bone  marrow  transp I  ant at I  on  from  volunteer  donors  was  approved  In 
1989  and  wl  II. start  In  early; 1990. 
The  general  aim  of  the  project  Is  to  create  In  the  respective  areas 
of  donor  pool  and  search  coordination,  the  necessary  conditions  to 
Increase  the  number  of  patl~nts with  haematologlcal  mal  lgnancles  who 
can  be  treated  by  unrelated !volunteer  bone  marrow  transplantation  and 
therefore  be  cured of  their  ~ancer of  the  bone  marrow. 
If  successful,  unrelated  bone  marrow  transplantation  will  have  a 
major  Impact.  Until  now  the,  vast  majority  of  patients  who  could  be 
cured  by  bone  marrow  transplantation  lack  a  donor.  Bone  marrow 
transplantation  would  then  become  a  possibility  available  for  all 
patients  with  haematologlcal  diseases  which  cannot  be  cured  by  means· 
other  than  transplantation  of  healthy  normal  bone  marrow.  It  Is 
estimated  that  this  would  quadruple  the  number  of  leukaemic  patients 
being  cured  within  the  next  decade. 
6.  A  concerted  action  on  the  •pathogenesis,  diagnosis  and  therapy  of 
tumour  progression  In  human  melanoma  and  precursor  lesions  was 
approved  In  1989  and  wl  11  start  In  early  1990. 
The  objectives are  : 
-to  Identify  the  organization  and  function  of  the  genes  coding  for 
progression  antigens  and  their  products,  and  to  prepare 
(monoclonal)  antibodies  recognizing  these  progression antigens; 
to  IdentIfy  ant I  gens  that  pred 1 ct  the  suscept I  b i 1 I ty  and  effect  of 
Immunotherapy  In  melanoma  patients  and  to  study  the  mechanisms  of 
escape  from  Immune  response  as  a  man I festat ton  of  tumour 
progression  In  melanoma  patients; 
to prepare  vaccines,  useful  for  Immunotherapy; 
to  perform  dose-response  studies  on  the  Induct ton  of  cutaneous 
melanoma  In  the  opossum  (Monodelphis  domestlca)  by  UV  radiation. 
7.  A  concerted  action  on  the  molecular  and  cellular  strategies  for 
Immunotherapy  of  cancer  was  approved  In  1989  and  wl  1 I  start  In  early 
1990.  The  purpose  of  the  project  Is  to  elucidate  the  complex 
Immunologic  Interrelationship between  the  host  and  the  tumour,  and  to 
manipulate  this relationship  for  the  purpose  of  diagnosis,  prevention 
and  treatment  of  cancer. 
8.  A concerted  action  on  the  molecular  genetics  of  human  thyroid  cancer 
was  approved  In  1989  and  wl  Jr'  start  in  early  1990. - 27  -
The  objectives are  : 
- to  1  ncr ease  our  understandIng  of  the  causes  of  cancer  through  a 
cooperative  project  on  an  ·uncommon  group  of  tumours  with  well-
defined  Inherited  and  environmental  causative  factors;  · 
to  Identify-the  somatic  and  hereditary  genetic  abnormalities  which 
occur  at  each  stage  In  the  development  of  sporadic  (follicular 
cell)  and  faml 1  lal  (C  cell)  thyroid  cancer; 
to  use  results  on  thyroid  as  a  simple  model  for  understanding  the 
bas I  c  me chan 1  sms  of  tumour I  genesIs  in  human  ep It he I I  a  In  genera I . 
and  hence  to provide  Insight  Into  cancers of  more  complex  eplthel Ia 
such  as breast. 
9.  A concerted action on  genetics  In  cancer  families  with  primary  regard 
to  Faml I Ia I  Adenomatous  Polyposis  (FAP)  was  approved  In  1989  and  wl  I I 
start  In  early  1990. 
The  aim  of  this  concerted  action  Is  to  optimize  the  posslbll ltles of 
prevention  and  management  of  the  disease  (or  diseases)  In  the  EC. 
This  requires efficient  Identification and  registration of  FAP-cases. 
For  those  famll ies  who  choose  to  make  use  of  eff lclent  dlagnost ic 
methods  under  further  development  In  this  programme,- such  cases  could 
be  prevented  If  this were  In  accordance  with  the  wishes  and  norms  of 
the  families  Involved.  A successful  implementation  of  such  measures 
for  polyposis  could  eventually  serve  as  a  model  for  other .hereditary 
cancers. 
10  A concerted  action  on  the  relation  between  DNA  repair  and  cancer  was 
approved  In  1989  and  wl  I I  start  In  early  1990. 
It  alms  at  a  better  understanding  of  mechanisms  of  DNA  repair  and 
their  relationship  to  cancer,  in  particular  (I)  mechanisms  of  action 
of  carcinogens,  (II)  variation  in  response  to  carcinogens  In  the 
population,  (Ill)  basis  of  cancer-prone  DNA  repair  disorders,  (lv) 
Interaction  of  carcinogens  with  DNA  and  short-term  tests,  (v) 
mechanisms  of  chemotherapeutic  drugs. 
11  A  concerted  action  on  molecular  cytogenetics  of  solid  tumours  was 
approved  In  1989  and  wl  I I  start  ln.early  1990. 
It  alms  at  :  development  of  totally  new  diagnostic  protocols_and 
reagents  to  type  re 1  I  ab I  y  and  eas I I  y  the  rna jor  forms  of  so I I  d 
tumours.  The  diagnostic  protocols  wl  I I  be  based  upon  molecular 
cytogenetics. 
12  A concerted action on  optimization of  hyperthermia  technology  and  the 
assessment  of  Its  cl lnlcal  efficacy  was  approved  In  1989  and  It  wll I 
start  In  early  1990. 
The  objectives are  : 
-to  Improve  hyperthermia  technologies  and  determine  guidelines  for 
Improving  the  qual-Ity  of  treatment; 
-to  assess  the  efficacy  of  hyperthermia  In  combination  with 
radiotherapy  In  cancer  treatment. 
13  The  Commission  finances  a  concerted  action on  development  of  medical 
laser  applications.  The  alms  are  to  Improve  and  to  standardize  the 
knowledge  and  practice-of  the  use_  of  lasers  In  medicine  and  surgery. 
It  concentrates on  safety and  ~umour  therapy. - 28  -
Action  68  Co-financing  of  a  Eurooean  network  of  data  banks  for 
bybrldomas  <eel Is Producing monoclonal  antibodies) 
The  Community  has  co-financed,  from  November  1985  to. date,  the 
development  of  the  European  centre of  the  hybridoma  and  lmmunoclone  data 
bank  of  CODATA  (the  International  Counci I  of  Scientific  Unions' 
Committee  on  Data  for  Science  and  Technology).  CODATA  relies  on  three 
centres,  located  In  Europe  (Centre  de  R&D  in  lmmunoclones  In  the  Faculty 
of  Medicine  In  Nice),  the  United  States  (American  Type  Culture 
Collection,  Rockville,  Md.)  and  Japan  (Tokyo).  The  data  collected  by 
each  centre are  made  available  to  alI  three. 
The  present  European  centre  Is  extending  Its ·dissemination/collection/ 
pub! lcatlon activities  through  other  forms  of  European  col laboratlon,  In 
particular  electronic  networks,  starting  with  an  experiment  using 
France's  Mlnltel  network.  The  database  is  also  now  mounted  on  DIMDI, 
Koln,  the  German  Institute  for  Medical  Documentation  and  Information. 
For  further  details,  contact  Dr.  Louis  Rechaussat,  CERDIC,  Nice  (tel. 
33/93.20.01.80). 
Action  69  ;  Co-financing  by  the  European  Community  of  research  Into 
genetic  engineering  and  protein  engineering.  technlgues  potentially 
useful  for  the development  of anti-cancer  drugs 
A  number  of  projects  under  the  Biotechnology  Action  Programme  (1985-
1989)  aimed  at  achieving  a  better  understanding  of  the  relationship 
between  structure  and  function  of  eel lular  proteins.  This  fundamental 
approach  wl  I I  eventually  allow  the  study  of  proteins specific for  tumour 
eel Is  (such  as mutated  receptors  for  growth  hormones)  and  their  function 
in  the  oncogenic  process.  In  one  particular  project  the  elongation 
factor  Tu  (EF-Tu)  was·  studied,  a  protein  closely  related  to  oncogene 
products  such  as  p21.  The  work  done  by  the  three ·laboratories  Involved 
has  given  much  more  Insight  Into  the  str~cture/function  relationship of 
EF-Tu.  The  Biotechnology  Action  Programme  wi  I I  be  followed  by  the 
BRIDGE  programme  (1990-1993)  In  which  these  areas  of  research  will 
continue  to be  covered. 
Act !on  70  Co-t I  nanc I  ng  by  the  European  CommunIty  of  research  on  the 
targeting of cancer-killing drugs. 
The  project  on  cancer  treatment  by  drug  targeting with  neocarzlnostatln, 
wh.l ch  was  star  ted  In  1988,  has  now  deve 1  oped  Into  a  concerted  act I  on 
entitled:  Drug  targeting  :  lmmunoconjugates  for  cancer  therapy.  It  l"s 
the  Intention  to  develop  monoclonal  antibody-neocarzlnostatln conjugates 
and  to  test  them  for  their  tumour  specificity  both  in  yltro and  In  ylyo. 
A second  concerted  action  on  drug  targeting  was  also  started  In  1989  : 
Targeting  Systems  In  Cancer  Chemotherapy  :  Drug  Carrier  Systems. 
During  the  period  of  funding,  It  is  expected  that  candidate  carrier 
systems  containing  mitomycin  Cor  biological  response  modifiers  for  each 
of  ·three  target  areas  (liver,  lymph  nodes  and  bone  marrow)  wl  I I  have 
been  evaluated  In  animal  models.  Limited  cl lnlcal  studies  with 
promising systems  wl  I I  either  have  been  planned or  even  conducted  before 
the  end of  1992. - 29  -
Act I  on  71  :  Co-t I  nanc I  ng  by  the  European  CommunIty  of  research  on  the 
Pharmacology  of  anti-tumour  substances 
The  Biotechnology  Action  Programme  (1985-1989)  has  Included  a  pharmaco-
toxlcology ·research  project  In  the  area  of  cancer.  Many  of  the  results 
are  already  published  (a  list  of  publications  Is  available  from  DG 
XII/F/2;  furthermore,  some  of  the  newly  developed  systems  are  already 
used  for  pharmacotoxlcologlcal  studies  by  industry. 
Action  72  :  Harmonisation of  testing standards  for  anti-cancer  drugs 
The  EEC  Committee  for  Proprietary  Medicinal  Products  (CPMP)  has,  In 
accordance  wl th  the  concerted  procedure  for  the  author I sat I  on  before 
marketing  of  a  medicinal  product  foreseen  in  directive  87/22/EEC,  given 
a  favourable  opinion  for  an  lnterleukln-2,  indicated  in  treatment  of 
renal  cancer.  The  CPMP  has  also  pursued  Its  work  In  the  field  of 
harmonisation  by  elaborating  explanatory  notes  for  appl lcants  for 
marketing  authorisation.  These  explanatory  notes  deal  In  particular 
with  good  clinical  practice  for  trials  with  medicinal  products,  with 
cl lnical  trials  for  anti-cancer  drugs,  and  with  radlolabel led  monoclonal 
antibodies.  The  drafts  of  these  explanatory  notes  were  circulated  for 
consultation and  wl  1 I  be  final lsed  1n  1990. 
Proposed  action  73  :  Co-financing  by  the  European  Community  of  research 
Into  the  human  genome 
This  project  may  be  carried  out  under  the  Human  Genome  Analysis 
Programme  proposal.  Final  discussions  of  this  proposal  will  take  place 
In  1990  In  the  European  Pari lament  and  in  the  Councl I  of  Ministers. 
Proposed  action 74  :  Co-financing  by  the  European  Community  of  research 
on  nuclear  acid orobes 
This  project  may  be  carried  out  under  the  Human  Genome  Analysis 
Programme  proposal.  Final  discussions  of  this  proposal  will  take  place 
In  1990  In  the  European  Pari lament  and  in  the  Council  of Ministers. 
Action 75  :  Co-financing  by  the  Eurooean  Community  of  research on  cancer 
In  deyeloolng countries 
In  tropical  areas  there  Is  a  relatively  high  incidence  of  cancers  for 
which  viral  Infections  are  suspected  of  praying  a  role  In  their 
aetiology. 
Liver  cancer  Is  frequent  In  tropical  areas,  probably  due  to  the  high 
prevalence  o_f  hepatitis.  The  Commission  currently  finances  four 
research  projects  on  I lver  cancer.  The  aim  of  two  of  these  projects  Is 
to  study  the·  role  at  the  molecular  level  of  the  hepatitis  B  virus  on 
hepatic  oncogenesis.  The  goals  of  the  third  projects  are  :  (a)  to 
detect  and  characterize  hepatitis  B virus  variants  and  to  analyse  their 
role  In  primary  I iver  cancer  In  Senegal;  (b)  to  Identify  and  analyse 
chromosomal.deletl-ons  In  liver  cancer·,  as·well  as  genetic  predisposition 
to  this  type  of  cancer. - 30  -
The  basis objective  of  the  fourth  proJect  is  to  develop  the  analysis  of 
the  control  mechanisms  of  the  alpha-foetoproteln  gene  expression,  so  as 
to  understand  how  and  why  this gene  IS  onl~ expressed  In  hepatoma  eel Is. 
the  applied  object lve  of  this  study  is  to  create  the  basis  of  a  new 
approach  to  hepatoma  therapy. 
Other  studies  Indicate  a  high  percentage  of  spumaretrovlrus  (HSRV) 
Infect Ions  among  nasopharyngea I  care i noma  patIents  from  East  AfrIca. 
The  Commission  finances  a  study  which  plans  to  dev~lop a  rei fable,  rapl~ 
HSRV-speclflc  test  syste~ (ELISA)  i~ order  to screen  for  the  presence  of 
HSRV  In  Afr lean  patIents  suffering  from  degeneratIve  or 
lymphoprol Iterative  diseases  such  as  nasopharyngeal  carcinoma.  The 
results of  this  study  are  expected  to  make  It  possible  to  correlate  and 
study  the  prevalence of  an  HSRV  Infection  in  certain  human  diseases. 
'The  CommIssIon  Is  a I  so  fInancing  a  project. whose  a lm  Is  to  identIfy 
putative  tumour  viruses  In  AIDS-assoc·iated  malignancies  such  as  Kaposi's 
sarcoma  and  non-Hodgkin  lymphoma  and  to  analyse  an  association  of 
further  specific  tumours  with  human  immunodeficiency  virus  (HiV) 
Infection. - 31  -
CONCLUSION 
Over  the  past  three  years  the  European  CommunIty  has  demonstrated  Its 
abll lty  to  make  Its  own  major  contribution  to  the  fight  against  cancer, 
by  no  longer  restricting  Itself  to  Its  conventional  activities-measures 
to  combat  carcinogenic  chemicals  (ECSC  and  EEC  Treaties)  or  Ionizing 
radiation  (Euratom  Treaty)  - but  by  extending  Its  sphere  of  action  to 
new  areas  such  as  discouraging  the  use  of  tobacco,  improving  nutrition, 
cancer  screening,  training  of  medical  personne),  health  information  and 
education,  and  medical  research.  On  the  whole,  the  results  have  been 
most  satisfactory. 
a)  Legislation:  Several  pieces of  Community  legislation were  announced, 
concerning  the  discouragement  of  tobacco  use  (6),  Improvement  of 
nutrition  (1),  and  measures  to  combat  carcinogenic  chemicals  (3)  and 
Ionizing  radlat ion  (3).  Out  of  13  proposals,  only  one  (on  the 
prohibition  of  tax-free  tobacco  sales)  was  not  drawn  up  on  schedule. 
Seven  out  of  the  other  twelve  have  already  been  adopted  by  the 
Council  (labelling  of  tobacco  products,  ban  on  smoking  In  public 
places,  protection  against  ionizing  radiation  (3),  protection against 
care I  nogen I  c  chemIca Is  (2)).  The  Counc i I  has  adopted  common 
positions  on  three  others  (prohibition  of  cigarettes  with  a  high  tar 
content,  nutritional  labelling,  protection  of  .workers).  The  other 
two  are still  being  discussed  by·  the  Council  (tax  burden  on  tobacco, 
limitation  of  advertising  of  tobacco  products  in  the  press  and  by 
means  of  bl I Is  and  posters). 
b)  Actions  financed  by  the  Community  bydget:  An  average  of  around 
9  mi  I I ion  ECU  was  available  from  1987  to  1989  to  help  finance  actions 
In  the  fields  of  research,  prevention,  training,  Information  and 
health  education.  Although  on  the  low  side,  this  budget  stl I I 
enabled  progress  to  be  made  in  each  of  the  four  sections  of  the 
programme.  However,  as  far  as  Information  Is  concerned,  the  European 
Year  would  not  have  been  possible  without  the  much  larger  amounts 
Invested  by  the  non-governmental  cancer  organizations  and  the  active 
cooperation of  major  television stations  In  most  Member  States of  the 
European  Community. 
This  Europe.:n-scale  action  will  be  continued  and  extended  under  the 
second  plan  of  action  1990-1994,  which  the  Counci 1  wi  I I  adopt  on  17  May 
1990.  A  complete  assessment  of  the  programme,  particularly  Its 
scientific components,  wi  I I  be  made  pub I ic  early  In  1992. 
*  *  *  * 
*  * 
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